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Abstract
Background: Over 19% of the population ≥ 40 years of age in Barbados are diabetic. The quality of diabetes
primary care is uncertain.
Findings: Charts of diabetic and hypertensive patients were randomly sampled at all public and 20 private sector
primary care clinics. Charts of all diabetic patients ≥ 40 years of age were then selected. Processes of care, and
quality targets for blood pressure (BP), fasting blood glucose (FBG) and glycosylated haemoglobin (HbA1c) were
documented.
252 charts of diabetic patients (125 public and 127 private) were audited. Patients had the following characteristics:
mean age 64 years, female gender 61%, mean duration of diagnosis 9 years, and hypertension diagnosed 78%.
Patients had an average of 4.7 clinic visits per year, 66% were prescribed metformin, 68% a sulphonylurea, 25% a
statin, 21% insulin, 15% aspirin and 12% a glucosidase inhibitor. Public patients compared to private patients were
more likely to be female (77% vs. 46%, p < 0.01); have a longer duration of diagnosis (11.4 vs. 6.6 years, p < 0.01),
have more clinic visits per year (5.2 vs. 4.3, p < 0.01), and to be using insulin (28 vs. 15% p = 0.01). Over a 2 year
period, the proportion of charts with the following recorded at least once was: BP 98%, weight 80%, FBG 76%,
total cholesterol 72%, urine tested for albumin 66%, serum creatinine 62%, dietary advice 61%, exercise advice 49%,
lipid profile 48%, foot examination 41%, HbA1c 33%, dietician referral 23%, retinal examination 18%, tobacco use
17%, body mass index 0%, and waist circumference 0%. Public patients were more likely to have recorded: weight
(92% vs. 68%, p = < 0.01); tests for total cholesterol (78% vs. 65%, p = 0.02), albuminuria (72% vs. 59%, p = 0.03),
serum creatinine (79% vs. 44%, p < 0.01), and foot examination (50% vs. 32%, p = < 0.01); dietician referral (37% vs.
8%, p < 0.01), and tobacco use (26% vs. 8%, p < 0.01). For those tested, the most recent BP was < 140/90 for 43%,
HBA1c was < 7% for 28%, and FBG was < 6.7 mmol/L for 27%.
Conclusions: Interventions such as body mass assessment, lifestyle advice, screening for retinopathy, monitoring
blood glucose control, and achieving BP and glycaemic targets need improvement.
Background
Diabetes mellitus with an estimated prevalence of 19.4%
in people 40 years of age and over in Barbados [1] places
a significant demand on health care resources. Complica-
tions directly related to diabetes add to the problem. For
example the diabetes-related lower extremity amputation
rate has been estimated as 936 per 100,000 people in
Barbados, making it one of the highest in the world [2].
In addition, it has been estimated that 29% of those with
diabetes have diabetic retinopathy [1].
Diabetes primary care is mainly done by general practi-
tioners. Comprehensive public sector care is done at no
cost to the patient, whereas patients seen in the private
sector pay a fee. Medication to treat both diabetes and
hypertension is available to patients in both sectors at no
cost. An audit of diabetic primary care patients con-
ducted prior to 1995 in Barbados revealed deficiencies in
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blood glucose (FBG) < 8 mmol/L
-1 or random blood glu-
cose < 10 mmol/L
-1, and 17% of patients on hypertension
treatment had their BP controlled to < 140/90 [3].
The Commonwealth Caribbean Medical Research
Council (CCMRC), now the Caribbean Health Research
Council (CHRC), developed and distributed practice
guidelines, Managing Diabetes in Primary Care,i n1 9 9 5
[4]. However, aside from some seminars no specific
implementation or evaluation strategies were carried
out. The only published evaluation of care since the
release of the 1995 CCMRC guidelines was an audit of
public sector patients done some 4 months afterwards
[5]. This was published in the form of a brief abstract
only. In 2001 the Ministry of Health of Barbados devel-
oped the Protocol for the Monitoring, Surveillance and
Management of Diabetes Mellitus in Barbados,w h i c h
was implemented by seminars directed only at public
sector health professionals [6]. A revised version of the
CHRC diabetes guideline was disseminated in early 2006
[7] without any specific implementation and evaluation
strategies.
Although guidelines have the potential to improve
both the process of care and patient health outcomes
[8,9], when they are evaluated they are often found to
fall short of expectations [8,10,11]. The main reason
identified for this by a systematic review was less than
satisfactory adoption of guidelines by practitioners [12].
This study was done in 2005, prior to the publication
and dissemination of the revised CHRC Diabetes guide-
lines. The aims were to evaluate the actual status of care
of persons with diabetes in primary care in Barbados by
means of a chart audit, to determine how closely this
care adhered to the 1995 CCMRC guidelines and more
recent protocol, and to provide baseline data to allow
the effectiveness of the 2006 CHRC guidelines to be
judged in the future. Another important aim of the clin-
ical audit process was to identify deficiencies and pro-
vide the basis for implementing change aimed at
improving patient care. A comparison of the private and
public care was made as differences in system, practi-
tioner and patient factors between sectors may affect
guideline adoption and achievement of quality targets.
Methods
Setting
The population of Barbados was 268,792 at the last cen-
sus in 2000, of which 95.6% were of African origin [13].
The island is 430 km
2, and has a good road network.
Eight public sector polyclinics strategically located
around the island provide free comprehensive primary
care, while in 2005 at least 89 private general practi-
tioners were providing service for a fee. All Barbadians
are entitled to public sector care. Robust data is not
available but it has been estimated that primary care is
approximately equally split between the public and pri-
vate sectors [14].
At public sector polyclinics hypertensive patients are
often seen by a nurse who may record the BP, weight
and urine test results, before the consultation with the
general practitioner. A dietician and podiatrist are avail-
able at each clinic on specific days. All polyclinics have
a pharmacy. Most private practitioners work in solo or
small group practices, and do not employ a nurse. Many
patients seen privately do not have health insurance, but
drugs for the treatment of diabetes and glucometer test
strips are provided at no cost to both public and private
sector patients by the Barbados Drug Service.
Chart audit instrument
A chart audit instrument was developed to measure the
quality of patient care using indicators derived from the
C a r i b b e a na n dB a r b a d o sg u i d e l i n e s[ 4 , 6 ] ,a sw e l la s
other sources such as the Diabetes Quality Improvement
Project (DQIP) [15]. The indicators used included: each
visit documentation of weight, blood pressure and glu-
cose control; biannual HbA1c; annual retinal and foot
examinations, lipid profile, and screen for proteinuria/
microalbuminuria; and maintenance of blood pressure
below 140/90 (as recommended in the guidelines) and
HBA1c below 7%. For each patient, age, sex, duration of
disease, co-morbidity, medications, and health care
source (private or public sector) were recorded. Identify-
ing information concerning patients, and health care
providers were not collected. Data were collected for a
2-year period ending on date of the last entry into the
chart for diabetes. Processes of diabetes care were
assessed by noting if they were documented at least
once over a 2-year period. The 2-year interval was cho-
sen as it allowed for reasonable delays such as for the
return of lab results and delayed appointments when
assessing items recommended to be done yearly.
Chart sampling and data analysis
One hundred charts of patients with diabetes were
selected from the public sector polyclinics, and the same
number from 20 private physicians. Inclusion criteria
were: at least one visit for diabetes in the last year by a
patient at least 40 years of age; and diabetes documen-
ted in the chart at least 2 years prior to that visit. For
the public sector, 100 charts were selected overall, with
the number selected at each polyclinic in proportion to
the number of patients seen annually by that polyclinic.
Private physicians were selected from a previously vali-
dated list containing 89 names and asked to participate
in a focus group study on diabetes and hypertension. At
the end of the focus group session physicians were
asked to participate in a chart audit. Only one refused.
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g r o u p sb e c a u s et h e yw e r en o ta v a i l a b l ea tt h et i m et h e
sessions were held were recruited to make a total of 20
physicians. Since the annual number of patients seen by
individual private physicians is unknown, the 20 physi-
cians were asked to contribute 5 charts each. Charts
were selected randomly at the various sites, using (a)
random numbers if a numerical charting system existed
or (b) randomly selected shelves and files within shelves
if an alphabetical system existed. This method of rando-
misation should allow generalisation of results to all
persons over age 40 with diabetes obtaining medical
care for it in Barbados in the two year period studied.
An equal number of charts of patients with hyperten-
sion were also selected in the same way as part of a
study on hypertension care conducted at the same time
[16], and those who had diabetes were also included in
this study.
Ethical approval
Approval was obtained from the Institutional Review
Board of the University of the West Indies, Cave Hill
Campus and the Ministry of Health, Barbados.
Results
A total of 253 charts of diabetic patients were audited
(199 selected because the patient was diabetic and 54
because the patient was hypertensive but also had dia-
betes), 126 from public polyclinics and 127 from private
practitioners. One public clinic contributed 2 less charts
than the required number.
The mean age of patients was 64 years, the mean
duration of diagnosis was 9 years, 61% were female, and
78% were hypertensive. Patients had an average of 4.7
clinic visits per year, 68% were prescribed a sulphony-
lurea, 66% metformin, 25% a statin, 21% insulin, 15%
aspirin, and 12% a glucosidase inhibitor. Patients attend-
ing public clinics were more likely than private patients
to be female, have vascular disease recorded, to be pre-
scribed insulin, make more clinic visits per year, and to
have been diagnosed with diabetes for a greater dura-
tion. Private physicians’ patients were significantly hea-
vier. Otherwise the private and public patients were
similar (Table 1).
Most patients did not have a recording during a 2-
year period of the following items: physical examination
(height, body mass index (BMI), waist circumference,
and foot and retinal examination); lifestyle history and
advice (alcohol use, tobacco use, and exercise advice);
laboratory investigations (HbA1c and lipid profile);
referral to a dietician, and patient self blood glucose
monitoring (Table 2). Public patients compared to pri-
vate patients were more likely to have recorded in their
charts over a 2-year period the following items: weight,
foot examination, total cholesterol, serum creatinine,
urine albumin, and history and/or advice on such life-
style items as alcohol and tobacco use, diet advice as
well as referral to a dietician. Urine albumin testing was
Table 1 Characteristics of diabetic patients according to whether they attended public or private clinics (n = 253)
Categorical
Characteristic
Number (%) Number (%) attending public
clinic n = 126
Number (%) attending private
clinic n = 127
P value by Chi
Square
Gender**: Male 97 (39) 29 (23) 68 (54) < 0.01
Female 154 (61) 97 (77) 57 (46)
Have hypertension* 144 (72) 71 (72) 73 (73) 0.95
Have vascular disease 33 (13) 23 (18) 10 (8) 0.01
On Statin 63 (25) 34 (27) 29 (23) 0.45
On Biguanide 167 (66) 77(61) 90 (71) 0.10
On Sulphonylurea 172 (68) 80 (64) 92 (72) 0.13
On Insulin 54 (21) 35 (28) 19 (15) 0.01
On Glucosidase 30 (12) 12 (10) 18 (14) 0.25
On aspirin 39 (15) 20 (16) 19 (15) 0.84
Continuous
Characteristic
Number with
valid data
Mean (SD) Mean attending public clinic Mean attending
private clinic
P value by
t-test
Age (years) 252 64 (12) 65.3 63.3 .17
Weight (kg) 202 82 (21) 76.5 88.2 .00
Clinic visits/yr 251 4.7 (1.7) 5.2 4.3 < .01
Years since first
recorded diagnosis
246 9.0 (5.9) 11.4 6.6 < .01
*Only the 199 persons (99 public and 100 private) selected because they were diabetic are included. The 54 persons selected because they had hypertension,
but also happened to have diabetes are excluded.
** For gender, n = 251 (126 public and 125 private)
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being by routine clinic dipstick.
Since weight, blood pressure, and FBG are recom-
mended to be measured at each visit, and visits are
recommended every quarter, to meet guideline recom-
mendations, a patient should have 4 readings of each
recorded per year (table 3). The remaining variables in
table 3 are recommended every year, or on average, 2 in
2 years. Only the frequency of blood pressure recordings
and urine dipstick testing for albumin on average met
the target. Although patients of private practitioners
had, on average, fewer recordings of blood pressure
(also had fewer clinic visits), both settings achieved the
target of 4 readings per year. Private patients had on
average fewer weights, blood pressures, foot examina-
tions, urine albumin and cholesterol tests recorded, but
had more FBG tests than public patients.
Table 4 indicates the proportion of patients meeting
quality targets. Most patients had at least 4 visits per
year, but low proportions met the clinical targets with
the exception of diastolic blood pressure < 90 and the
sub-optimal HbA1c < 10. Of persons who had tests
done 27% were controlled with a FBG < 6.7, 45% had a
FBG < 8 mmol/L, and 28% had an HBA1c < 7%. Despite
private physicians tendency to do fewer tests and record
fewer items, similar proportions of patients from the 2
sectors met clinical targets, except that private clinics
exceeded public clinics in meeting the sub-optimal
HbA1c target.
Discussion
Despite adequate access to health care, with an average
of 4.7 clinic visits per year, many patients did not have
recommended processes of care such as history taking,
lifestyle advice, physical examination, and laboratory
tests performed, and many did not achieve blood glu-
cose and BP control. A chart audit cannot identify many
of the factors influencing quality of care. A focus group
study done at about the same time as this chart audit
identified barriers to good care, but also found that
many practitioners were of the opinion that they pro-
vided good care [17].
Table 2 Number and proportion of diabetic patients having various processes of care recorded at least once in last 2
years by health care source (n = 253 unless otherwise stated)
Process of care Number (%) with process recorded in
the chart
Number (%) attending
public clinic
n = 126
Number (%) attending
private clinic
n = 127
P value by Chi
Square
Height 5 (2) 2 (2) 3 (2) 1.00
Weight 202 (80) 116 (92) 86 (68) .00
BMI 1 (0.4) 1 (1) 0 (0) .50
Waist
circumference
0 (0) 0 (0) 0 (0) -
Blood pressure 247 (98) 122 (97) 125 (98) .44
Foot examination 104 (41) 63 (50) 41 (32) .00
Retinal
examination
46 (18) 24 (19) 22 (17) .70
Fasting blood
glucose
192 (76) 98 (78) 94 (74) .51
SBGM* being
done
64 (25) 29 (23) 35 (28) .43
HbA1c† 85 (33) 48 (38) 37 (29) .15
Urine albumin‡ 165 (66) 90 (72) 75 (59) .03
Serum creatinine 155 (62) 99 (79) 56 (44) .00
Total cholesterol 181 (72) 98 (78) 83 (65) .02
Lipid profile 120 (48) 63 (50) 57 (45) .38
Alcohol use
recorded
48 (19) 34 (27) 14 (11) .00
Tobacco use
recorded
42 (17) 32 (26) 10 (8) .00
Diet advice given 153 (61) 86 (68) 67 (53) .01
Referred to
dietician
57(23) 47 (37) 10 (8) .00
Exercise advice 124 (49) 65 (52) 59 (47) .37
*Self blood glucose monitoring
†Glycosylated haemoglobin
‡Tests done by routine dipstick or laboratory testing.
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The control of obesity is important in the treatment of
diabetes. Even though patients on average had their
weight recorded 3 times per year, no chart had a record-
ing of waist circumference, and only 1 had a BMI docu-
mented over a 2-year period. Barbadians may
underestimate their level of overweight and obesity [18].
Discussing BMI and waist circumference with patients
may therefore be necessary when trying to promote
weight loss. Waist circumference is an independent and
stronger predictor of cardiovascular risk than BMI, and is
useful both in initial assessment and in monitoring the
efficacy of weight loss measures [19,20]. However, waist
circumference, and BMI are not mentioned in the
CCMRC guideline [4], and except at initial assessment
are not mentioned in the Ministry of Health protocol [6].
Documentation of dietary advice and referral to a die-
tician were recorded in only 61% and 23% of charts
respectively with the public sector doing better than the
private. A dietician is available to public patients at no
cost at each polyclinic, whereas private patients are unli-
kely to have a dietician located in their doctor’s office
and in addition have to pay for this service. Women are
more likely to influence eating habits in the household
and attend public clinics more frequently. These facts
may help to explain the higher rate of dietician referral
in the public sector.
A history of alcohol and tobacco use was noted in less
than 20% of charts. Despite the low prevalence of cigar-
ette smoking in Barbados [21], this information is needed
to calculate cardiac risk and to plan treatment [22].
Eye and foot examination
Few patients had retinal examinations. Fundoscopy with
adequate dilation of pupils is time consuming, and pos-
sibly the physician may lack confidence in properly
Table 3 Means of continuous characteristics of diabetic patients according to whether they attended public or private
clinic
Characteristic Mean (SD) for all
patients
Mean for public
patients
Mean for private
patients
P value by t
test
Number with valid
data
Number of diabetic
medications
1.7 (0.8) 1.7 1.7 .97 252
Total number of
medications
3.9 (1.8) 3.9 3.9 .96 251
Weights recorded/yr 3.0 (1.9) 3.4 2.5 .01 235
Blood pressures/yr 4.5 (1.6) 4.8 4.3 .01 251
Fasting blood glucoses/yr 1.3 (1.2) 1.1 1.6 .01 243
HbA1c/2 yr 0.7 (1.4) 0.7 0.8 .54 240
Urine albumin/2 yr 2.5 (2.8) 3.0 1.9 .00 234
Foot exams/2 yr 1.1 (1.7) 1.4 0.8 .00 245
Retinal assessments/2 yr 0.30 (0.62) 0.36 0.24 .14 247
Cholesterols/2 yr 1.1 (1.0) 1.3 1.0 .01 246
Table 4 Number and Proportion of diabetic patients meeting quality targets at last visit by health care source
Target Number
with valid
data
Number (%)
meeting
target
Number (%) attending
public clinic who met
target
Number (%) attending
private clinic who met
target
P value by Chi Square for
difference between public and
private
Systolic BP < 140 247 119 (48) 61 (50) 58 (46) .57
Diastolic BP < 90 247 182 (74) 87 (71) 95 (76) .40
Both systolic Bp <
140 and diastolic Bp
<9 0
247 106 (43) 55 (45) 51 (41) .50
FBG* < 6.7 (good†) 192 51 (27) 31 (32) 20 (21) .10
FBG
1 <8
(acceptable†)
192 87 (45) 49 (50) 38 (40) .18
HbA1c < 7 (optimal†) 85 24 (28) 12 (25) 12 (32) .45
HbA1c < 10 (sub-
optimal‡)
85 69 (81) 35 (73) 34 (92) .03
4 or more visits in 1
yr
252 216 (86) 110 (88) 106 (84) .30
*Fasting blood glucose
†As defined in Managing Diabetes in Primary Care
4 ‡As defined in Protocol for the Monitoring, Surveillance and Management of Diabetes Mellitus in Barbados
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common with 29% of people with diabetes ≥ 40 years of
age estimated to have the condition [1].
Foot examination was documented at least once in 2
years in only 41% of charts. Barbados has a high lower
extremity amputation rate, with inadequate footwear
shown to independently increase amputation risk (odds
ratio 2.71, 95% confidence interval 1.23- 5.97) [2].
Blood pressure
Most patients had hypertension, with 72% of those
selected on the basis of diabetes having hypertension.
Blood pressure was monitored in almost all patients and
at an adequate frequency. Terminal digit preference
would have affected the quality of the measurement
[16]. Only 43% of all patients, including those not diag-
nosed with hypertension, had a blood pressure less than
140/90 mmHg at the last visit. A previous Barbados
chart audit revealed a BP control rate of 17%, but
included only those on treatment for hypertension in
that estimate [3]. In comparison over 58% of diabetic
patients receiving commercial care and Medicare in the
USA in 2006 had their BP controlled to < 140/90 [23].
The UKPDS showed that 6.1 patients (95% confidence
interval 2.6 to 9.5) need to be treated with tight control
of blood pressure (mean blood pressure 144/82) vs. less
tight control (mean blood pressure 154/87) over 10
years to prevent one patient from developing any com-
plication, and 15.0 (12.1 to 17.9) to prevent death from
a cause related to diabetes [24]. In our study 52% of our
patients would have met the UKPDS tight control
target.
Glycaemic assessment
Glycaemic control was not adequately monitored, and
most of those with data available were not controlled to
target. In a two-year period two thirds of patients did not
have an HBA1c test, 24% did not have a FBG (with an
average of 1.3 tests per patient per year), and only a quar-
ter were noted to be self blood glucose monitoring. In a
majority of cases therefore neither health care worker
nor patient could be confident about the level of glycae-
mic control attained. For the HbA1c test, important fac-
tors might be availability in the public sector (reflecting
cost to the Ministry of Health), and cost to the private
patient (about US$23 per test). The study was not
designed to determine if physicians recognised the utility
of the test. For self-monitoring, patient acceptance, and
cost of the glucometer and lancets might be factors.
Patient factors can be important e.g. the laboratory FBG
test cannot be done unless the patient agrees to fast.
Of the patients who were monitored few attained
guideline recommended glycaemic quality targets [4,6],
with 28% achieving an HbA1c of < 7%, and 81% the
sub-optimal target of < 10%. As few persons had this
test, selection bias is likely and the findings should be
cautiously interpreted. Only 45% of patients had a FBG
< 8 mmol/L. This compares with a similar result found
prior to the introduction of the CCMRC guidelines in
1995 in which 49% of patients attending public clinics
and 66% attending private clinics had a FBG < 8 mmol/l
or a random glucose < 10 mmol/l [3]. Based on volunta-
rily reported data by health plans in 2006, 87% of adult
diabetics receiving commercial care and Medicare in the
USA had HBA1c testing, > 42% had HBA1c levels < 7%,
and > 70% had HBA1c levels ≤ 9% [23]. The National
Health and Nutrition Examination Survey a population-
based survey in the USA estimated control rates
(HBA1c < 7%) for adults with a previous diagnosis of
diabetes had progressively increased from 37% in 1999-
2000 to 56% in 2003-2004 [25], suggesting that improve-
ment should also be possible in Barbados.
Laboratory tests
Forty eight percent of patients had a lipid profile in 2
years, although 72% of patients had the total cholesterol
done. In the public sector the laboratory may not always
have reagent to do a full profile. In the private sector
the lipid profile at a cost of about US $45 may be unaf-
fordable for the patient.
A serum creatinine was done in 44%, and urine was
tested for albumin in 59% of private patients compared
to 79% and 72% respectively of public patients. A creati-
nine plus electrolytes costs about US $45 privately. Test-
ing for protein was mainly by dipstick for clinical
proteinuria. In public clinics, a nurse tests the urine,
whereas the private sector physician often does not
employ a nurse. Urine can only be tested if a patient
provides it, and this would be facilitated by having suita-
ble facilities for collecting it at the clinic. Testing for
microalbuminuria, which is the earliest manifestation of
diabetic nephropathy, is not a requirement of the
CCMRC guideline [4] but is required in the more recent
Ministry of Health protocol [6].
Treatment
The CCMRC guidelines [4] recommend that obese
patients be treated with metformin, and sulphonylureas
then added if necessary. More patients might therefore
have been expected to have been on metformin. The
significantly higher use of insulin by public compared to
private patients may reflect the fact that public patients
have been diagnosed with diabetes longer. Only a quar-
ter of patients were on a statin, and 15% on aspirin.
Neither of the guidelines emphasizes the use of these
medications. Private patients under the age of 65 years
are required to pay for statins and may be deterred by
the cost.
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Private patients were twice as likely as public patients to
b em a l e .M a l e sm a yb em o r el i k e l yt ob ew o r k i n ga n d
have a greater income than females and therefore may
be better able to afford private care, and may find
attending the private practitioner less time consuming
and more convenient.
Limitations
Limitations were similar to that of the audit of hyper-
tension care conducted at the same time [16]. As the
sample included charts of patients who were hyperten-
sive but also had diabetes, a slightly higher proportion
of charts of hypertensive patients were audited than if
selection was on the basis of diabetes only (72% vs.
78%).
Conclusions
There appears to have been no progress in the quality of
glycaemic control in over 10 years in Barbados despite
the creation and distribution of guidelines Effective
guideline adoption requires more than disseminating the
guideline. Multiple ongoing interventions are needed in
order to enable and reinforce the required changes, and
the impact needs to be monitored and evaluated.
Repeated educational sessions are needed to familiarise
health care workers with guideline recommendations,
and necessary resources must be provided to facilitate
change. Strategies shown to be effective in some settings
include repeated audit and feedback, reminder systems,
patient education, academic detailing and financial
incentives [12,26-28]. Altering reimbursement systems
to reward practitioners who meet certain care targets
would be difficult in Barbados as such information is
not available to funders. Although simple office proce-
dures such as measuring height, weight, waist circumfer-
ence, and urine albumin; taking adequate histories and
giving advice requires only staff time, human resources
can be costly. Improving compliance with retinal exami-
nation may require the introduction of retinal photo-
graphic screening. Laboratory tests must be available in
the public sector, and affordable in the private sector. In
primary care many other aspects of patient care com-
pete for physician’st i m ea st h e“whole person” and not
just the “diabetic” is looked after. The whole person
aspects cannot be neglected, as they are likely to impact
on the patient’s interest and participation in their dia-
betic care, and adherence to the necessary regimens.
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